CDC Health Advisory for H1N1 Anti-viral treatment

In this revised health advisory, the CDC is re-iterating the need for early anti-viral treatment for suspected H1N1 infection. Given the low sensitivity of rapid diagnostic tests for H1N1, patients with suspected infection should be treated regardless of the result (and treatment should not be deferred until results are available). Treatment should be considered in all hospitalized patients with confirmed or suspected H1N1, as well as those non-hospitalized, but at risk for complications (including age >65 or <2, pregnant women, and those with chronic or immunosuppressive medical conditions, listed on the CDC website) (site)

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment